SCHEMBL14012102

SCHEMBL14012102

CC(=O)N[C@H](CCC(=O)OCc1ccccc1)C(=O)N[C@@H](CCC(=O)OCc1ccccc1)C(=O)NCCOCCOCCN=[N+]=[N-]

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.60
▸ ALDH1A1 P00352 1/20 0.60
▸ HPGD P15428 1/20 0.60
▸ KMT2A Q03164 1/20 0.60
▸ BCHE P06276 2/20 0.41
▸ ACHE P22303 2/20 0.41
▸ CACNA1C Q13936 2/20 0.41
▸ CACNA1F O60840 1/20 0.41
▸ CACNA1D Q01668 1/20 0.41
▸ CACNA1S Q13698 1/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ LMNA P02545 1/20 0.41
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA3 P07451 1/20 0.40
▸ CA4 P22748 1/20 0.40
▸ CA6 P23280 1/20 0.40
▸ CA5A P35218 1/20 0.40
▸ CA7 P43166 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16572489 1.00 MEN1 (0.60) MEN1ALDH1A1HPGDKMT2ABCHE
SCHEMBL14012034 1.00 MEN1 (0.60) MEN1ALDH1A1HPGDKMT2ABCHE
SCHEMBL13881696 0.99 MEN1 (0.61) MEN1ALDH1A1HPGDKMT2ABCHE
SCHEMBL13625022 0.98 MEN1 (0.62) MEN1ALDH1A1HPGDKMT2ABCHE
SCHEMBL16572491 0.98 MEN1 (0.62) MEN1ALDH1A1HPGDKMT2ABCHE
SCHEMBL13890398 0.96 MEN1 (0.56) MEN1ALDH1A1HPGDKMT2ABCHE
SCHEMBL13881694 0.96 MEN1 (0.56) MEN1ALDH1A1HPGDKMT2ABCHE
SCHEMBL13890399 0.96 MEN1 (0.56) MEN1ALDH1A1HPGDKMT2ABCHE
SCHEMBL13625013 0.96 MEN1 (0.56) MEN1ALDH1A1HPGDKMT2ABCHE
SCHEMBL13890402 0.95 MEN1 (0.55) MEN1ALDH1A1HPGDKMT2ABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7799339-B2 Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery INTEZYNE TECHNOLOGIES, INC. (US) 2010-09-21 — — US disclosed
US-20080274173-A1 Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery INTEZYNE TECHNOLOGIES, INC. (US) 2008-11-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080274173-A1 Copolymer of crosslinkable or crosslinked poly(amino acid block), and a hydrophobic D,L-mixed poly(amino acid) block; an inner core, crosslinked outer core, a hydrophilic shell; improved in vivo circulation time; drug delivery CLTB, SLC1A5, CLTA MEN1 2136/4885ALDH1A1 3966/4885HPGD 2992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback